This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| New Zealand Cancer Registry | |
|---|---|
| Name | New Zealand Cancer Registry |
| Type | National disease registry |
| Formed | 1958 |
| Jurisdiction | New Zealand |
| Headquarters | Wellington |
| Parent agency | Ministry of Health (New Zealand) |
New Zealand Cancer Registry is the national population-based registry that records information on cancer incidence within New Zealand. It supports surveillance, research, health policy, and clinical planning by compiling data on malignant neoplasms, registration dates, and basic demographic details. The registry interacts with national and international institutions to ensure standardised coding, data linkage, and reporting.
The registry began in 1958 amid public health initiatives associated with the Department of Health (New Zealand), developing alongside regional services such as the Auckland District Health Board and the Otago District Health Board. Early development involved collaborations with hospitals including Wellington Hospital, cancer centres like Christchurch Hospital, and pathology services tied to institutions such as the University of Otago. International influence came from organisations such as the World Health Organization, the International Agency for Research on Cancer, and registry models from Scotland and Sweden. Over decades the registry's operations adapted to legislative changes from statutes debated in the New Zealand Parliament and to technological shifts driven by suppliers like ESR (Institute of Environmental Science and Research) and national IT projects of the Ministry of Health (New Zealand).
Administrative oversight involves the Ministry of Health (New Zealand), with operational relationships to regional bodies such as the Canterbury District Health Board and national laboratories including Auckland City Hospital Pathology. Governance draws on standards from agencies such as the Health Research Council of New Zealand, and accountability reporting aligns with frameworks used by entities like Statistics New Zealand and the Privacy Commissioner (New Zealand). Advisory input has come from clinical organisations including the New Zealand Medical Association, specialist colleges such as the Royal Australasian College of Physicians, and consumer groups like Cancer Society of New Zealand.
Case ascertainment is achieved via mandated notifications from hospitals such as Middlemore Hospital, private clinics including oncology units at Auckland Cancer Centre, histopathology laboratories like Labtests NZ, and death registrations managed by the Department of Internal Affairs (New Zealand). Coverage spans all New Zealand residents, with demographic linkage to datasets maintained by Statistics New Zealand and electoral roll information from the Electoral Commission (New Zealand) to improve completeness. Data sources include hospital discharge records from district health boards such as Hutt Valley District Health Board, radiotherapy centres like those at Christchurch Radiotherapy Centre, and pathology reports from institutions including Gribbles Veterinary Pathology-related labs in historical contexts.
Tumour classification follows international frameworks promoted by the International Classification of Diseases and by the International Agency for Research on Cancer, with morphology and topography coded using systems developed by organisations like the World Health Organization. The registry utilises coding standards consistent with the ICD-O series and aligns staging practice with guidelines from bodies such as the Union for International Cancer Control and clinical staging protocols used by speciality groups including the New Zealand Society of Oncologists.
Outputs include national incidence reports comparable to publications from the International Agency for Research on Cancer, statistical tables for planners at the Ministry of Health (New Zealand), and research datasets used by universities such as the University of Auckland and the University of Otago. The registry informs service planning for facilities like Waikato Hospital, contributes to survivorship studies linked with the Hawke's Bay District Health Board, and supports monitoring initiatives led by the Cancer Society of New Zealand and clinical trials coordinated through networks such as the Trans-Tasman Radiation Oncology Group.
Quality assurance practices are modelled on international registry protocols from the International Association of Cancer Registries and include automated checks, manual abstraction reviews, and periodic audits similar to exercises run by the European Network of Cancer Registries. Linkage with mortality data from the Department of Internal Affairs (New Zealand) and demographic records from Statistics New Zealand supports validation. Peer review and methodological guidance have been provided by research groups at institutions like the Oxford University and the University of Sydney in collaborative studies.
Operations are governed by New Zealand statutes overseen by the Privacy Commissioner (New Zealand), and ethical oversight involves committees modelled on the Health and Disability Ethics Committees (New Zealand). Data-sharing agreements conform to expectations set by the Ministry of Health (New Zealand) and inter-agency memoranda with organisations such as the Accident Compensation Corporation. Research access follows approval pathways used by universities like the University of Canterbury and funders such as the Health Research Council of New Zealand.
The registry underpins epidemiological research published in journals and utilised by international projects such as those coordinated by the International Agency for Research on Cancer and comparative studies involving registries in Australia, Canada, and United Kingdom. Findings have informed national cancer control strategies adopted by the Ministry of Health (New Zealand), targeted screening programs in partnership with the National Screening Unit (New Zealand), and Māori health equity work involving organisations like Te Puni Kōkiri. Outcomes have supported policy decisions affecting services at hospitals including Auckland City Hospital and influenced clinical guidelines promulgated by the New Zealand Guidelines Group.
Category:Health organisations based in New Zealand Category:Cancer registries